Showing results (1041-1050 of 1,404) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|May 31, 2019
Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1BYoshito Nishimura, Hidenori Wake, Kiyoshi Teshigawara, et al.
Pharmacology Research & Perspectives|June 6, 2019
Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modelingMarthe F Fjelldal, Thibaud Freyd, Linn M Evenseth, et al.
Pharmacology Research & Perspectives|March 15, 2022
Dexamethasone promotes breast cancer stem cells in obese and not lean miceStephanie Annett, Orla Willis Fox, Damir Vareslija, et al.
Pharmacology Research & Perspectives|April 25, 2022
Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscleKeyue Xu, Miyuki Shimizu, Chika Murai, et al.
Pharmacology Research & Perspectives|March 26, 2022
The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarkerMatthew J Lawrence, Vanessa Evans, Janet Whitley, et al.
Pharmacology Research & Perspectives|October 19, 2021
In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitorHeather Zhang, Ying C Ou, Dan Su, et al.
Pharmacology Research & Perspectives|October 19, 2021
Antibiotic use and associated factors in adult outpatients from 2000 to 2019Carlotta Franchi, Sara Mandelli, Ida Fortino, et al.
Pharmacology Research & Perspectives|September 29, 2021
Polypharmacology of clinical sodium glucose co-transport protein 2 inhibitors and relationship to suspected adverse drug reactionsKaran Matharu, Kiran Chana, Charles J Ferro, et al.
Pharmacology Research & Perspectives|October 10, 2021
Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteersNaoto Noda, Takeshi Takagaki, Yasuhide Yodo, et al.
Pharmacology Research & Perspectives|October 26, 2021
Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patientsFlorine A Berger, Willem van Weteringen, Heleen van der Sijs, et al.
Pageof 141